Can One Dose of Dexamethasone Cause Acute Behavioral and Psychological Changes in Children?
Yes, even a single dose of dexamethasone can cause insomnia, behavioral changes, and psychological disturbances in pediatric patients, though the risk and severity vary significantly by age, dose, and individual sensitivity.
Evidence from Drug Labeling and Clinical Practice
The FDA-approved prescribing information for dexamethasone explicitly warns that "psychic derangements may appear when corticosteroids are used, ranging from euphoria, insomnia, mood swings, personality changes, and severe depression to frank psychotic manifestations" 1. This warning applies to any corticosteroid use, including single doses, and the label notes that "existing emotional instability or psychotic tendencies may be aggravated by corticosteroids" 1.
Age-Dependent Risk Profile
The likelihood and severity of acute neurobehavioral effects are strongly age-dependent:
- Preschool children (<6 years) are at substantially higher risk for acute behavioral side effects compared to older children 2
- In a prospective study, preschool children showed significant increases (P < 0.001) in emotional dyscontrol, mood disturbances, behavioral dysregulation, and executive function problems during active steroid treatment, while school-age children (≥6 years) and adolescents did not demonstrate these acute increases 2
- These effects were transient, returning to baseline during "off-steroid" weeks 2
Specific Behavioral Manifestations
Research in pediatric populations receiving dexamethasone documents the following acute effects:
- Sleep disruption and insomnia are among the most common and pronounced effects 3, 4
- Children taking dexamethasone experience significantly more night awakenings and poorer sleep quality compared to those on prednisone 3
- Behavioral problems including mood swings, irritability, and emotional lability occur frequently 5, 2
- Sleep disturbances account for nearly half of the variance in health-related quality of life during corticosteroid treatment 3
Dose Considerations
While the provided evidence focuses primarily on repeated dosing in oncology protocols, the FDA labeling makes clear that psychiatric effects can occur with any corticosteroid exposure 1. The systematic review on psychiatric adverse effects notes that "patients as well as caregivers should be warned of the potential for behavioral adverse effects when patients receive these drugs" 6, without limiting this warning to chronic or high-dose use.
Clinical Implications and Monitoring
Key points for clinical practice:
- Warn families proactively before administering dexamethasone, particularly for children under 6 years of age
- Insomnia and sleep disturbances are the most predictable acute effects
- Behavioral changes typically manifest within hours to days of administration
- Younger children require closer monitoring and more intensive family counseling about expected behavioral changes
- Individual glucocorticoid sensitivity varies significantly, making some children more susceptible to these effects 5
Important Caveats
The evidence base has limitations: most pediatric data comes from oncology protocols with repeated dosing rather than single-dose studies 6. However, the FDA drug labeling does not distinguish between single and repeated doses when warning about psychiatric effects 1. The mechanism involves direct glucocorticoid receptor binding in the hippocampus and other brain regions 7, which occurs with any exposure.
In real-world practice, assume that any child receiving dexamethasone—even a single dose—can develop acute behavioral changes, with preschool-aged children at highest risk. Families should be counseled accordingly, and monitoring should be age-appropriate.